Evoke Pharma Inc (EVOK) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 95 transactions totaling $5.6M, demonstrating a bearish sentiment with -$587.4K in net insider flow. The most recent transaction on Dec 17, 2025 involved a transaction of 148,153 shares valued at $1.6M.
No significant insider buying has been recorded for EVOK in the recent period.
No significant insider selling has been recorded for EVOK in the recent period.
Based on recent SEC filings, insider sentiment for EVOK is bearish with an Insider Alignment Score of 45/100 and a net flow of -$587.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Evoke Pharma Inc (EVOK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading EVOK stock, having executed 95 transactions in the past 90 days. The most active insider is Daniel Mack (Executive), who has made 1 transactions totaling $1.6M.
Get notified when executives and directors at EVOK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Mack Daniel | Executive | Other | 148,153 | $11.00 | $1.6M | Large |
| Dec 16, 2025 | J. D'onofrio Matthew | Executive | Tender | 15,509 | $N/A | $0 | |
| Dec 16, 2025 | C. Brady Todd | Executive | Tender | 27 | $N/A | $0 | |
| Dec 16, 2025 | Kowieski Mark | Executive | Tender | 11,815 | $N/A | $0 | |
| Dec 16, 2025 | R. Hill Malcolm | Executive | Tender | 133 | $N/A | $0 | |
| Dec 16, 2025 | L. Garner Cam | Executive | Tender | 2,330 | $N/A | $0 | |
| Dec 16, 2025 | R. Carlson Marilyn | Executive | Tender | 360 | $N/A | $0 | |
| Nov 6, 2025 | M. Klein Roger | Executive | Sale | 4,000 | $10.65 | $42.6K | |
| Nov 6, 2025 | M. Klein Roger | Executive | Sale | 5,000 | $10.66 | $53.3K | |
| Dec 14, 2020 | A. Gonyer David | Executive | Sale | 23,954 | $2.94 | $70.4K | |
| Dec 11, 2020 | J. D'onofrio Matthew | Executive | Sale | 40,357 | $2.91 | $117.4K | |
| Dec 11, 2020 | A. Gonyer David | Executive | Sale | 48,046 | $2.90 | $139.3K | |
| Dec 10, 2020 | J. D'onofrio Matthew | Executive | Sale | 5,643 | $2.95 | $16.6K | |
| Dec 9, 2020 | J. D'onofrio Matthew | Executive | Option Exercise | 46,000 | $0.40 | $18.4K | |
| Dec 9, 2020 | A. Gonyer David | Executive | Option Exercise | 72,000 | $0.40 | $28.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 32 | $3.1M | 40.4% |
Purchase(P) | 7 | $2.5M | 32.8% |
Other(J) | 24 | $2.0M | 25.9% |
Exercise(M) | 3 | $48.7K | 0.6% |
Award(A) | 1 | $21.3K | 0.3% |
Tender(U) | 6 | $0 | 0.0% |
Conversion(C) | 22 | $0 | 0.0% |
Insider activity at Evoke Pharma Inc shows mixed signals across all time. While $2.5M in purchases indicates some executive confidence,$3.1M in sales balances the picture, resulting in a modest net flow of -$587.4K.21 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Daniel Mack, has transacted $1.6M during this period.